The elderly comprises over one-third of hepatocellular carcinoma (HCC) patients, however,
they are not adequately represented in prognostic studies. The study aims to determine the …

Purpose The prevention of recurrence for patients with hepatocellular carcinoma after
curative resection is still a great challenge in clinical practice. There are numerous studies …

Purpose There is little information regarding the overall survival (OS) predictive ability of the
combination of tumor burden score (TBS), α-fetoprotein (AFP), and albumin-bilirubin (ALBI) …

Background The most common cause of death for colon cancer patients is liver metastasis.
Methods All the data enrolled in this study were downloaded from two public databases, The …

Hepatocellular carcinoma (HCC) is the fourth leading cause of cancer death worldwide and
its prognosis is highly heterogeneous, being related not only to underlying chronic liver …

Background The severity of liver cirrhosis in hepatocellular carcinoma (HCC) patients is
essential for determining the scope of surgical resection. It also affects the long-term efficacy …

Background The high recurrence rate of hepatocellular carcinoma (HCC) after surgery
negatively affects the prognosis of patients. There is currently no widely accepted adjuvant …

Purpose The evidence of apatinib plus immune checkpoint inhibitors (ICIs) and transarterial
chemoembolization (TACE) for treating advanced hepatocellular carcinoma (HCC) is …

The objective of this study is to explore the effect of plantamajoside on malignant properties
of MHCC97H cells and its possible mediating molecular mechanisms. Effects of high …

Parecoxib, a well‐recognized nonsteroidal anti‐inflammatory drug, has been reported to
possess anticancer properties in various tumor types. In this work, we aimed to investigate …